- Home
- VNDA vs FTF Comparison
VNDA vs FTF Comparison
Compare VNDA & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FTF
- Stock Information
- Founded
- VNDA 2002
- FTF 2003
- Country
- VNDA United States
- FTF United States
- Employees
- VNDA N/A
- FTF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FTF Finance/Investors Services
- Sector
- VNDA Health Care
- FTF Finance
- Exchange
- VNDA Nasdaq
- FTF Nasdaq
- Market Cap
- VNDA 249.4M
- FTF 256.6M
- IPO Year
- VNDA 2006
- FTF N/A
- Fundamental
- Price
- VNDA $5.46
- FTF $6.39
- Analyst Decision
- VNDA Strong Buy
- FTF
- Analyst Count
- VNDA 2
- FTF 0
- Target Price
- VNDA $16.50
- FTF N/A
- AVG Volume (30 Days)
- VNDA 503.6K
- FTF 153.9K
- Earning Date
- VNDA 11-05-2025
- FTF 01-01-0001
- Dividend Yield
- VNDA N/A
- FTF 11.45%
- EPS Growth
- VNDA N/A
- FTF N/A
- EPS
- VNDA N/A
- FTF N/A
- Revenue
- VNDA $203,467,000.00
- FTF N/A
- Revenue This Year
- VNDA $15.45
- FTF N/A
- Revenue Next Year
- VNDA $37.82
- FTF N/A
- P/E Ratio
- VNDA N/A
- FTF N/A
- Revenue Growth
- VNDA 11.78
- FTF N/A
- 52 Week Low
- VNDA $3.81
- FTF $5.76
- 52 Week High
- VNDA $5.59
- FTF $6.56
- Technical
- Relative Strength Index (RSI)
- VNDA 67.52
- FTF 47.48
- Support Level
- VNDA $5.22
- FTF $6.33
- Resistance Level
- VNDA $5.48
- FTF $6.40
- Average True Range (ATR)
- VNDA 0.21
- FTF 0.04
- MACD
- VNDA 0.06
- FTF -0.00
- Stochastic Oscillator
- VNDA 90.31
- FTF 41.67
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.